

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation (GO:0006956) | 9.99585267 |
| 2 | positive regulation of respiratory burst (GO:0060267) | 7.65755872 |
| 3 | protein activation cascade (GO:0072376) | 7.31677444 |
| 4 | glomerular filtration (GO:0003094) | 6.78545802 |
| 5 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 6.23288523 |
| 6 | Fc-gamma receptor signaling pathway (GO:0038094) | 6.23288523 |
| 7 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 6.23288523 |
| 8 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 6.20134069 |
| 9 | renal filtration (GO:0097205) | 6.11030954 |
| 10 | humoral immune response (GO:0006959) | 5.61426481 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.40242217 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.31998117 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.11800598 |
| 14 | regulation of respiratory burst (GO:0060263) | 5.00100828 |
| 15 | antibacterial humoral response (GO:0019731) | 4.82449649 |
| 16 | antimicrobial humoral response (GO:0019730) | 4.77003330 |
| 17 | regulation of cellular extravasation (GO:0002691) | 4.59941894 |
| 18 | retina homeostasis (GO:0001895) | 4.22913504 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.04130596 |
| 20 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.97296703 |
| 21 | germinal center formation (GO:0002467) | 3.87294982 |
| 22 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.85423240 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 3.82866410 |
| 24 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.77588356 |
| 25 | chronic inflammatory response (GO:0002544) | 3.73121926 |
| 26 | negative regulation of cell killing (GO:0031342) | 3.71382551 |
| 27 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.71382551 |
| 28 | regulation of antigen processing and presentation (GO:0002577) | 3.66519131 |
| 29 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.55247634 |
| 30 | detection of other organism (GO:0098543) | 3.41991089 |
| 31 | detection of bacterium (GO:0016045) | 3.32959999 |
| 32 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.30203593 |
| 33 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.29595568 |
| 34 | positive regulation of antigen processing and presentation (GO:0002579) | 3.25863514 |
| 35 | regulation of integrin activation (GO:0033623) | 3.24920496 |
| 36 | cellular response to type I interferon (GO:0071357) | 3.20076647 |
| 37 | type I interferon signaling pathway (GO:0060337) | 3.20076647 |
| 38 | negative regulation of myotube differentiation (GO:0010832) | 3.16597969 |
| 39 | response to type I interferon (GO:0034340) | 3.16446207 |
| 40 | eosinophil chemotaxis (GO:0048245) | 3.04546176 |
| 41 | dendritic cell chemotaxis (GO:0002407) | 2.99667607 |
| 42 | immune response-activating signal transduction (GO:0002757) | 2.94098258 |
| 43 | wound healing, spreading of epidermal cells (GO:0035313) | 2.91982881 |
| 44 | negative regulation of complement activation (GO:0045916) | 2.90855256 |
| 45 | cellular extravasation (GO:0045123) | 2.90379120 |
| 46 | cellular response to interferon-gamma (GO:0071346) | 2.87790970 |
| 47 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.87494319 |
| 48 | activation of immune response (GO:0002253) | 2.87125661 |
| 49 | B cell mediated immunity (GO:0019724) | 2.86392759 |
| 50 | eosinophil migration (GO:0072677) | 2.84165390 |
| 51 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.81443317 |
| 52 | positive regulation of type 2 immune response (GO:0002830) | 2.81428439 |
| 53 | negative regulation of humoral immune response (GO:0002921) | 2.79973873 |
| 54 | surfactant homeostasis (GO:0043129) | 2.79165650 |
| 55 | response to interleukin-15 (GO:0070672) | 2.78129015 |
| 56 | detection of external biotic stimulus (GO:0098581) | 2.76324941 |
| 57 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.76272627 |
| 58 | response to interferon-gamma (GO:0034341) | 2.75191751 |
| 59 | respiratory burst (GO:0045730) | 2.74537535 |
| 60 | production of molecular mediator of immune response (GO:0002440) | 2.71365242 |
| 61 | regulation of T cell tolerance induction (GO:0002664) | 2.70691263 |
| 62 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.66756820 |
| 63 | defense response to protozoan (GO:0042832) | 2.66171224 |
| 64 | dendritic cell migration (GO:0036336) | 2.65794168 |
| 65 | B cell receptor signaling pathway (GO:0050853) | 2.65459114 |
| 66 | regulation of necrotic cell death (GO:0010939) | 2.65251111 |
| 67 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.63674071 |
| 68 | positive regulation of chemokine secretion (GO:0090197) | 2.61770809 |
| 69 | protein-chromophore linkage (GO:0018298) | 2.59031727 |
| 70 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.58706008 |
| 71 | positive regulation of response to oxidative stress (GO:1902884) | 2.58706008 |
| 72 | myeloid dendritic cell differentiation (GO:0043011) | 2.58609664 |
| 73 | lymphocyte chemotaxis (GO:0048247) | 2.57462053 |
| 74 | positive regulation of T cell migration (GO:2000406) | 2.55546597 |
| 75 | regulation of chemokine secretion (GO:0090196) | 2.54531172 |
| 76 | negative regulation of protein activation cascade (GO:2000258) | 2.54209141 |
| 77 | T-helper 1 type immune response (GO:0042088) | 2.52086992 |
| 78 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.52006385 |
| 79 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.50981932 |
| 80 | neutrophil activation involved in immune response (GO:0002283) | 2.49234926 |
| 81 | regulation of tolerance induction (GO:0002643) | 2.49232518 |
| 82 | negative regulation of bone resorption (GO:0045779) | 2.49198942 |
| 83 | regulation of T cell migration (GO:2000404) | 2.49086972 |
| 84 | regulation of regulatory T cell differentiation (GO:0045589) | 2.46306614 |
| 85 | lymph node development (GO:0048535) | 2.41120583 |
| 86 | positive regulation of B cell differentiation (GO:0045579) | 2.39269351 |
| 87 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.38220721 |
| 88 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.38220721 |
| 89 | modulation by symbiont of host immune response (GO:0052553) | 2.38220721 |
| 90 | positive regulation by symbiont of host defense response (GO:0052509) | 2.38220721 |
| 91 | modulation by symbiont of host defense response (GO:0052031) | 2.38220721 |
| 92 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.38220721 |
| 93 | regulation of gamma-delta T cell activation (GO:0046643) | 2.37946263 |
| 94 | immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 2.37207037 |
| 95 | positive regulation of pseudopodium assembly (GO:0031274) | 2.35802145 |
| 96 | macrophage activation involved in immune response (GO:0002281) | 2.35078161 |
| 97 | positive regulation of receptor recycling (GO:0001921) | 2.34329354 |
| 98 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.34247563 |
| 99 | myeloid dendritic cell activation (GO:0001773) | 2.34015716 |
| 100 | complement activation, classical pathway (GO:0006958) | 12.6033401 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.89581753 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.57292294 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.44816199 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.40053421 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.37807436 |
| 6 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.36268175 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.11153033 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.83657005 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.66965928 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.58216986 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.49546862 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.31944220 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.21713206 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.17203255 |
| 15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.14248094 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.13008505 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.05791350 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.05791179 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.97268387 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.88016045 |
| 21 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.87474694 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.83861948 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.81269727 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.76265617 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.68523395 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 1.60999050 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.60352456 |
| 28 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.59455267 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.56636601 |
| 30 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.55366045 |
| 31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.53585590 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.53270244 |
| 33 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.51937250 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.47877388 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44664164 |
| 36 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44114565 |
| 37 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.42531131 |
| 38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.39625513 |
| 39 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.37916032 |
| 40 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.37590224 |
| 41 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.36766352 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.35742906 |
| 43 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.35636568 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.34861855 |
| 45 | SPI1_23127762_ChIP-Seq_K562_Human | 1.34693174 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.33995448 |
| 47 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.32719488 |
| 48 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27337537 |
| 49 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.26895209 |
| 50 | MAF_26560356_Chip-Seq_TH1_Human | 1.23339920 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.22064793 |
| 52 | MYB_26560356_Chip-Seq_TH1_Human | 1.19570433 |
| 53 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.17638778 |
| 54 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14508772 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14354891 |
| 56 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14169160 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14039179 |
| 58 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12820611 |
| 59 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10355222 |
| 60 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.09103986 |
| 61 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.08532478 |
| 62 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08114678 |
| 63 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08098065 |
| 64 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.07843733 |
| 65 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.06585830 |
| 66 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.05185509 |
| 67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.04315674 |
| 68 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.04151345 |
| 69 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03993205 |
| 70 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02816859 |
| 71 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01911323 |
| 72 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.01200424 |
| 73 | MYC_22102868_ChIP-Seq_BL_Human | 0.99261003 |
| 74 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.99160947 |
| 75 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97693990 |
| 76 | GATA2_19941826_ChIP-Seq_K562_Human | 0.94374304 |
| 77 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94114294 |
| 78 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94102556 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93869418 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93359106 |
| 81 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92837279 |
| 82 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.92754697 |
| 83 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.91679149 |
| 84 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91052423 |
| 85 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.90401432 |
| 86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.89122045 |
| 87 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88722335 |
| 88 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.88532356 |
| 89 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87570098 |
| 90 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86567053 |
| 91 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.86449764 |
| 92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85758107 |
| 93 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.84831151 |
| 94 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.84723086 |
| 95 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82483573 |
| 96 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82032234 |
| 97 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.81968799 |
| 98 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81738918 |
| 99 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.81457699 |
| 100 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.80759491 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.33241171 |
| 2 | MP0003303_peritoneal_inflammation | 4.34008012 |
| 3 | MP0003436_decreased_susceptibility_to | 3.28836523 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.27639094 |
| 5 | MP0001790_abnormal_immune_system | 2.93146205 |
| 6 | MP0005387_immune_system_phenotype | 2.93146205 |
| 7 | MP0001800_abnormal_humoral_immune | 2.73054947 |
| 8 | MP0010155_abnormal_intestine_physiology | 2.66867675 |
| 9 | MP0005025_abnormal_response_to | 2.61579588 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 2.42158989 |
| 11 | MP0000685_abnormal_immune_system | 2.41101796 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.38910068 |
| 13 | MP0009785_altered_susceptibility_to | 2.38030789 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.27559406 |
| 15 | MP0005166_decreased_susceptibility_to | 2.27375274 |
| 16 | MP0000465_gastrointestinal_hemorrhage | 2.24698600 |
| 17 | MP0001533_abnormal_skeleton_physiology | 2.21799320 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.20206086 |
| 19 | MP0002419_abnormal_innate_immunity | 2.17226148 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.17068829 |
| 21 | MP0005671_abnormal_response_to | 2.05753000 |
| 22 | MP0005275_abnormal_skin_tensile | 2.02444753 |
| 23 | MP0002723_abnormal_immune_serum | 2.02415756 |
| 24 | MP0001819_abnormal_immune_cell | 1.97208405 |
| 25 | MP0002420_abnormal_adaptive_immunity | 1.97124262 |
| 26 | MP0001873_stomach_inflammation | 1.93049245 |
| 27 | MP0008004_abnormal_stomach_pH | 1.82343983 |
| 28 | MP0004264_abnormal_extraembryonic_tissu | 1.81755627 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.73386561 |
| 30 | MP0004782_abnormal_surfactant_physiolog | 1.72653272 |
| 31 | MP0003279_aneurysm | 1.72185349 |
| 32 | MP0003866_abnormal_defecation | 1.69601939 |
| 33 | MP0004947_skin_inflammation | 1.69340682 |
| 34 | MP0006082_CNS_inflammation | 1.69284187 |
| 35 | MP0002166_altered_tumor_susceptibility | 1.60364602 |
| 36 | MP0003075_altered_response_to | 1.52792221 |
| 37 | MP0003448_altered_tumor_morphology | 1.50764544 |
| 38 | MP0005023_abnormal_wound_healing | 1.50031200 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.49994636 |
| 40 | MP0008438_abnormal_cutaneous_collagen | 1.48821526 |
| 41 | MP0005503_abnormal_tendon_morphology | 1.46451723 |
| 42 | MP0000343_altered_response_to | 1.44939180 |
| 43 | MP0001663_abnormal_digestive_system | 1.44468048 |
| 44 | MP0010352_gastrointestinal_tract_polyps | 1.44369214 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.42851641 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.42546867 |
| 47 | MP0005310_abnormal_salivary_gland | 1.41797934 |
| 48 | MP0002933_joint_inflammation | 1.41238545 |
| 49 | MP0000716_abnormal_immune_system | 1.38370528 |
| 50 | MP0002405_respiratory_system_inflammati | 1.38217480 |
| 51 | MP0004858_abnormal_nervous_system | 1.36378906 |
| 52 | MP0003763_abnormal_thymus_physiology | 1.32173320 |
| 53 | MP0002398_abnormal_bone_marrow | 1.32169107 |
| 54 | MP0003045_fibrosis | 1.30219423 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.28363354 |
| 56 | MP0001851_eye_inflammation | 1.23898124 |
| 57 | MP0005164_abnormal_response_to | 1.22940256 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.22909040 |
| 59 | MP0003828_pulmonary_edema | 1.22609625 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.20103138 |
| 61 | MP0000604_amyloidosis | 1.17035758 |
| 62 | MP0005390_skeleton_phenotype | 1.16090564 |
| 63 | MP0002006_tumorigenesis | 1.14913279 |
| 64 | MP0009764_decreased_sensitivity_to | 1.11844379 |
| 65 | MP0008469_abnormal_protein_level | 1.11834585 |
| 66 | MP0002429_abnormal_blood_cell | 1.08051129 |
| 67 | MP0000858_altered_metastatic_potential | 1.03617546 |
| 68 | MP0005381_digestive/alimentary_phenotyp | 1.03296689 |
| 69 | MP0009278_abnormal_bone_marrow | 1.03166062 |
| 70 | MP0000249_abnormal_blood_vessel | 1.01233080 |
| 71 | MP0002722_abnormal_immune_system | 1.00411989 |
| 72 | MP0000689_abnormal_spleen_morphology | 1.00017137 |
| 73 | MP0002277_abnormal_respiratory_mucosa | 0.94922486 |
| 74 | MP0001542_abnormal_bone_strength | 0.94666503 |
| 75 | MP0001986_abnormal_taste_sensitivity | 0.93265356 |
| 76 | MP0005388_respiratory_system_phenotype | 0.93208082 |
| 77 | MP0002133_abnormal_respiratory_system | 0.93208082 |
| 78 | MP0003329_amyloid_beta_deposits | 0.91956759 |
| 79 | MP0000477_abnormal_intestine_morphology | 0.87134836 |
| 80 | MP0003566_abnormal_cell_adhesion | 0.87124831 |
| 81 | MP0005165_increased_susceptibility_to | 0.86949125 |
| 82 | MP0009840_abnormal_foam_cell | 0.86854316 |
| 83 | MP0001879_abnormal_lymphatic_vessel | 0.86419569 |
| 84 | MP0000490_abnormal_crypts_of | 0.85703908 |
| 85 | MP0003091_abnormal_cell_migration | 0.83706159 |
| 86 | MP0003795_abnormal_bone_structure | 0.81083700 |
| 87 | MP0003453_abnormal_keratinocyte_physiol | 0.76567832 |
| 88 | MP0005397_hematopoietic_system_phenotyp | 0.76434730 |
| 89 | MP0001545_abnormal_hematopoietic_system | 0.76434730 |
| 90 | MP0010368_abnormal_lymphatic_system | 0.76055016 |
| 91 | MP0004510_myositis | 0.75210415 |
| 92 | MP0001664_abnormal_digestion | 0.73228527 |
| 93 | MP0000681_abnormal_thyroid_gland | 0.73101184 |
| 94 | MP0008874_decreased_physiological_sensi | 0.72681883 |
| 95 | MP0008260_abnormal_autophagy | 0.71903782 |
| 96 | MP0001958_emphysema | 0.70428038 |
| 97 | MP0002896_abnormal_bone_mineralization | 0.69307017 |
| 98 | MP0001853_heart_inflammation | 0.68279460 |
| 99 | MP0006054_spinal_hemorrhage | 0.66471735 |
| 100 | MP0005085_abnormal_gallbladder_physiolo | 0.66119014 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prostate neoplasm (HP:0100787) | 9.32461097 |
| 2 | Abnormality of macrophages (HP:0004311) | 6.69588864 |
| 3 | Abnormality of the prostate (HP:0008775) | 6.05856039 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 5.93698375 |
| 5 | Vasculitis (HP:0002633) | 4.53507858 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.47412082 |
| 7 | Leukocytosis (HP:0001974) | 4.02149299 |
| 8 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.92871924 |
| 9 | Abnormality of complement system (HP:0005339) | 3.74129228 |
| 10 | Abnormality of male internal genitalia (HP:0000022) | 3.63211059 |
| 11 | Skin rash (HP:0000988) | 3.54206086 |
| 12 | Recurrent bronchitis (HP:0002837) | 3.53945321 |
| 13 | Glomerulonephritis (HP:0000099) | 3.51843076 |
| 14 | Agammaglobulinemia (HP:0004432) | 3.48076483 |
| 15 | Complement deficiency (HP:0004431) | 3.44268364 |
| 16 | Spontaneous hematomas (HP:0007420) | 3.40458591 |
| 17 | Recurrent abscess formation (HP:0002722) | 3.38143923 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.34809684 |
| 19 | Malnutrition (HP:0004395) | 3.33647815 |
| 20 | Gastrointestinal stroma tumor (HP:0100723) | 3.22896270 |
| 21 | Meningitis (HP:0001287) | 3.12767319 |
| 22 | Cellulitis (HP:0100658) | 3.09796855 |
| 23 | Gastrointestinal infarctions (HP:0005244) | 3.02569256 |
| 24 | Neoplasm of the lung (HP:0100526) | 2.98891773 |
| 25 | Urticaria (HP:0001025) | 2.93365663 |
| 26 | Colitis (HP:0002583) | 2.91209931 |
| 27 | Myositis (HP:0100614) | 2.90310981 |
| 28 | Nephritis (HP:0000123) | 2.89985853 |
| 29 | Osteomyelitis (HP:0002754) | 2.89151209 |
| 30 | Orchitis (HP:0100796) | 2.87890293 |
| 31 | Premature loss of primary teeth (HP:0006323) | 2.87783541 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.84849631 |
| 33 | Inflammation of the large intestine (HP:0002037) | 2.80023403 |
| 34 | Gingivitis (HP:0000230) | 2.73299582 |
| 35 | Gastrointestinal inflammation (HP:0004386) | 2.65976175 |
| 36 | Obstructive lung disease (HP:0006536) | 2.65755938 |
| 37 | Chronic obstructive pulmonary disease (HP:0006510) | 2.65755938 |
| 38 | Hemoptysis (HP:0002105) | 2.59241791 |
| 39 | Abnormality of the nasal mucosa (HP:0000433) | 2.59041892 |
| 40 | Neoplasm of the respiratory system (HP:0100606) | 2.58510244 |
| 41 | Abnormality of B cell number (HP:0010975) | 2.58316123 |
| 42 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.56221990 |
| 43 | Chronic otitis media (HP:0000389) | 2.53007656 |
| 44 | Mediastinal lymphadenopathy (HP:0100721) | 2.52806928 |
| 45 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.52115145 |
| 46 | Increased IgE level (HP:0003212) | 2.50324134 |
| 47 | Hypermelanotic macule (HP:0001034) | 2.48218315 |
| 48 | Pulmonary infiltrates (HP:0002113) | 2.45864293 |
| 49 | Optic neuritis (HP:0100653) | 2.40853205 |
| 50 | Retrobulbar optic neuritis (HP:0100654) | 2.40853205 |
| 51 | Chronic diarrhea (HP:0002028) | 2.38989930 |
| 52 | Recurrent viral infections (HP:0004429) | 2.38139081 |
| 53 | Polycythemia (HP:0001901) | 2.32183852 |
| 54 | Recurrent sinusitis (HP:0011108) | 2.31451197 |
| 55 | Recurrent skin infections (HP:0001581) | 2.31369969 |
| 56 | Emphysema (HP:0002097) | 2.22977180 |
| 57 | Recurrent fungal infections (HP:0002841) | 2.22168206 |
| 58 | Peritonitis (HP:0002586) | 2.17828635 |
| 59 | Gingival bleeding (HP:0000225) | 2.15341551 |
| 60 | Recurrent pneumonia (HP:0006532) | 2.15053218 |
| 61 | Hematochezia (HP:0002573) | 2.14198207 |
| 62 | Bronchitis (HP:0012387) | 2.13048488 |
| 63 | Chest pain (HP:0100749) | 2.11314691 |
| 64 | Purpura (HP:0000979) | 2.10938158 |
| 65 | Interstitial pulmonary disease (HP:0006530) | 2.10385552 |
| 66 | Ankyloglossia (HP:0010296) | 2.10200074 |
| 67 | Pustule (HP:0200039) | 2.08819085 |
| 68 | Abnormality of the peritoneum (HP:0002585) | 2.07869093 |
| 69 | Abnormality of T cell number (HP:0011839) | 2.07527640 |
| 70 | Metaphyseal cupping (HP:0003021) | 2.07312796 |
| 71 | Skin ulcer (HP:0200042) | 2.06937485 |
| 72 | Right ventricular cardiomyopathy (HP:0011663) | 2.06375708 |
| 73 | Restrictive lung disease (HP:0002091) | 2.01688383 |
| 74 | Recurrent cutaneous fungal infections (HP:0011370) | 2.00692840 |
| 75 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.00692840 |
| 76 | Hypergammaglobulinemia (HP:0010702) | 2.00549677 |
| 77 | Autoimmune thrombocytopenia (HP:0001973) | 1.99576946 |
| 78 | B lymphocytopenia (HP:0010976) | 1.99397239 |
| 79 | Recurrent lower respiratory tract infections (HP:0002783) | 1.99199138 |
| 80 | Xerostomia (HP:0000217) | 1.98898016 |
| 81 | Keratoconjunctivitis sicca (HP:0001097) | 1.97267412 |
| 82 | Verrucae (HP:0200043) | 1.96355552 |
| 83 | Papilloma (HP:0012740) | 1.96355552 |
| 84 | Increased IgM level (HP:0003496) | 1.95577619 |
| 85 | Periodontitis (HP:0000704) | 1.95550087 |
| 86 | Alopecia of scalp (HP:0002293) | 1.92029190 |
| 87 | Epistaxis (HP:0000421) | 1.88954833 |
| 88 | Villous atrophy (HP:0011473) | 1.88556428 |
| 89 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.88556428 |
| 90 | Autoimmune hemolytic anemia (HP:0001890) | 1.88179800 |
| 91 | Nasal polyposis (HP:0100582) | 1.87663261 |
| 92 | Lymphopenia (HP:0001888) | 1.87291163 |
| 93 | Hyperactive renin-angiotensin system (HP:0000841) | 1.86327029 |
| 94 | Pulmonary embolism (HP:0002204) | 1.85511587 |
| 95 | Fragile skin (HP:0001030) | 1.84962624 |
| 96 | Sepsis (HP:0100806) | 1.84860751 |
| 97 | Abnormality of the pleura (HP:0002103) | 1.84097540 |
| 98 | T lymphocytopenia (HP:0005403) | 1.84068042 |
| 99 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.83495061 |
| 100 | Abnormality of T cell physiology (HP:0011840) | 1.82485655 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.96644016 |
| 2 | TYK2 | 3.34029372 |
| 3 | MAP4K1 | 3.14312000 |
| 4 | RIPK4 | 2.90119150 |
| 5 | BLK | 2.83981085 |
| 6 | PRPF4B | 2.66221045 |
| 7 | FGFR4 | 2.50605606 |
| 8 | MST1R | 2.36015052 |
| 9 | EPHA3 | 2.24544764 |
| 10 | EPHB1 | 2.15065134 |
| 11 | KIT | 2.13286139 |
| 12 | RIPK1 | 2.08268617 |
| 13 | JAK1 | 2.00489273 |
| 14 | JAK3 | 1.99696991 |
| 15 | FES | 1.96925549 |
| 16 | IRAK4 | 1.89913643 |
| 17 | CSK | 1.88419852 |
| 18 | GRK6 | 1.85257014 |
| 19 | ZAP70 | 1.76319942 |
| 20 | CDC42BPA | 1.75853366 |
| 21 | TXK | 1.72636584 |
| 22 | PIK3CA | 1.63068063 |
| 23 | MAP3K14 | 1.62419008 |
| 24 | IKBKE | 1.60846253 |
| 25 | JAK2 | 1.55350183 |
| 26 | FGFR3 | 1.50565947 |
| 27 | TGFBR2 | 1.44424284 |
| 28 | MAP3K1 | 1.38850549 |
| 29 | LYN | 1.37950600 |
| 30 | SIK3 | 1.34186070 |
| 31 | SYK | 1.32641267 |
| 32 | PKN2 | 1.30604515 |
| 33 | MAP3K3 | 1.28880234 |
| 34 | IRAK1 | 1.27629662 |
| 35 | PDGFRA | 1.27387369 |
| 36 | TBK1 | 1.25137152 |
| 37 | BMPR2 | 1.19801295 |
| 38 | MAP2K3 | 1.19432825 |
| 39 | BTK | 1.18420736 |
| 40 | HCK | 1.15866199 |
| 41 | FER | 1.12199066 |
| 42 | MATK | 1.11237375 |
| 43 | CSF1R | 1.05246286 |
| 44 | YES1 | 1.04056516 |
| 45 | NLK | 1.02761087 |
| 46 | TAOK1 | 0.99395551 |
| 47 | MET | 0.97943153 |
| 48 | DDR2 | 0.90850008 |
| 49 | STK24 | 0.89803367 |
| 50 | FGR | 0.83300189 |
| 51 | MAP3K10 | 0.81057341 |
| 52 | TGFBR1 | 0.80782847 |
| 53 | RET | 0.79386656 |
| 54 | FLT3 | 0.76028493 |
| 55 | LCK | 0.75537348 |
| 56 | MAP3K13 | 0.75488472 |
| 57 | EPHB2 | 0.75387479 |
| 58 | TAOK3 | 0.69040397 |
| 59 | PTK6 | 0.68050465 |
| 60 | PDGFRB | 0.67199083 |
| 61 | PRKG2 | 0.66942397 |
| 62 | KSR2 | 0.66536444 |
| 63 | MAP3K6 | 0.65287120 |
| 64 | GRK5 | 0.65098321 |
| 65 | TEC | 0.63261915 |
| 66 | FYN | 0.61615630 |
| 67 | OXSR1 | 0.61278359 |
| 68 | PDPK1 | 0.60387363 |
| 69 | LRRK2 | 0.58622816 |
| 70 | TAOK2 | 0.56455694 |
| 71 | IKBKB | 0.56336307 |
| 72 | MYLK | 0.55259426 |
| 73 | HIPK2 | 0.54869185 |
| 74 | MAPK7 | 0.54661683 |
| 75 | ITK | 0.54442131 |
| 76 | STK39 | 0.54235366 |
| 77 | MAP3K2 | 0.51793339 |
| 78 | ACVR1B | 0.50399038 |
| 79 | PDK1 | 0.49927599 |
| 80 | CDK6 | 0.49496729 |
| 81 | TRIB3 | 0.48987684 |
| 82 | IGF1R | 0.46282382 |
| 83 | IRAK3 | 0.45140116 |
| 84 | EPHA2 | 0.43024752 |
| 85 | MAP3K11 | 0.41254484 |
| 86 | MAP3K12 | 0.41203572 |
| 87 | DMPK | 0.40596409 |
| 88 | MAP3K5 | 0.40441284 |
| 89 | IRAK2 | 0.37412121 |
| 90 | ABL1 | 0.36976085 |
| 91 | CLK1 | 0.36477223 |
| 92 | TNK2 | 0.35434589 |
| 93 | LMTK2 | 0.35391538 |
| 94 | MAPKAPK2 | 0.35167121 |
| 95 | PRKCQ | 0.34747683 |
| 96 | GRK1 | 0.34463836 |
| 97 | NEK9 | 0.33007579 |
| 98 | MAPK4 | 0.32779976 |
| 99 | PRKCD | 0.32699821 |
| 100 | MAPK11 | 0.31839174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.17407700 |
| 2 | Asthma_Homo sapiens_hsa05310 | 3.81177114 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.22357251 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.11319383 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.01654083 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.91018312 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.85093516 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.47022797 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.34138608 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.20680938 |
| 11 | Viral myocarditis_Homo sapiens_hsa05416 | 2.00150486 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.90927407 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.83849661 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.82049590 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.79270566 |
| 16 | Pertussis_Homo sapiens_hsa05133 | 1.78854228 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.74277461 |
| 18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.71099691 |
| 19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.68453588 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.62896050 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.61535211 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.44685944 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.41160238 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.35673161 |
| 25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.34657553 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.34569659 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.27186463 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.23892251 |
| 29 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.18374067 |
| 30 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.15577163 |
| 31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.12654587 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.12364213 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11318059 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01355307 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 0.99744633 |
| 36 | Measles_Homo sapiens_hsa05162 | 0.99355838 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.95311531 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.94954570 |
| 39 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.90481560 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88815182 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 0.88212155 |
| 42 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.88007085 |
| 43 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.87612961 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85824207 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.85678339 |
| 46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.84710515 |
| 47 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.84000694 |
| 48 | Amoebiasis_Homo sapiens_hsa05146 | 0.79144403 |
| 49 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.78191781 |
| 50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.77286323 |
| 51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.74475337 |
| 52 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.73791600 |
| 53 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.70455775 |
| 54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.68534126 |
| 55 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.65690507 |
| 56 | Legionellosis_Homo sapiens_hsa05134 | 0.63787922 |
| 57 | Salmonella infection_Homo sapiens_hsa05132 | 0.59984357 |
| 58 | Lysosome_Homo sapiens_hsa04142 | 0.59778576 |
| 59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59736916 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.58771107 |
| 61 | Apoptosis_Homo sapiens_hsa04210 | 0.57742543 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57283743 |
| 63 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.55025006 |
| 64 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.54799701 |
| 65 | Mineral absorption_Homo sapiens_hsa04978 | 0.53765509 |
| 66 | Hepatitis B_Homo sapiens_hsa05161 | 0.52532004 |
| 67 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.51033569 |
| 68 | Platelet activation_Homo sapiens_hsa04611 | 0.49123024 |
| 69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48679052 |
| 70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47724900 |
| 71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46809363 |
| 72 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.46148728 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45222831 |
| 74 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.42098533 |
| 75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40218441 |
| 76 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.39696413 |
| 77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39507216 |
| 78 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.38903056 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.37667166 |
| 80 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.37359168 |
| 81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35336375 |
| 82 | Shigellosis_Homo sapiens_hsa05131 | 0.35082776 |
| 83 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.34970220 |
| 84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34115552 |
| 85 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33949761 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.33857170 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.32561991 |
| 88 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.32320383 |
| 89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.29659704 |
| 90 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.29039373 |
| 91 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.28525619 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28346237 |
| 93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.27850233 |
| 94 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27532149 |
| 95 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.26589799 |
| 96 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.25592330 |
| 97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.25474614 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.25297694 |
| 99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.25099246 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.24940131 |

